Hims & Hers, the Telesalud and Welfare Company, has hired a veteran of the autonomous vehicle industry as its next technology director. The movement, according to the co -founder and CEO of Hims & Hers, Andrew Dudum, was intentional.
Hims & Hers on Thursday said their next CTO would be Mo ElShenawy, the former president and CTO of the Autonomous Autonomous Company Cruise. ElShenawy left the cruise earlier this year after its GM parent company Turn off the autonomous vehicle program.
The Salto de Avs to Health may seem unlikely, but Dudum told Techcrunch that he deliberately resorted to the autonomous management sector to find a CTO that helped his company to accelerate his product agenda based on AI.
“I was looking a lot at leaders in the autonomous driving space, explicitly because it is talking about taking advantage of technology and data and AI in an extremely sensitive environment in which you have the lives of people at risk,” Dudum said in an interview.
ElShenawy, who has more than 10 patents in AI, robotics and autonomous vehicles, told TechCrunch the movement “is not a jump as large as it seems.”
“Autonomous cars use AI to make real -time decisions in complex, high -risk and very regulated environments, where to gain confidence is everything,” he told Techcrunch in an email. “Medical care operates in the same conditions. You are dealing with the lives of people, limited resources and under stress systems. Translating AI in safe and reliable decision -making is directly applied to what we are building in Hims and hers.”
Hims and hers It is a San Francisco Telesalud company that was public in 2021 through a fusion with a special purpose acquisition company. Founded in 2017, Hims & Hers initially focused on the health of men, selling medications for erectile dysfunction and hair loss treatments. The following year, he expanded to women’s health and added “his” to the identification plate of his company. The direct consumer company, which connects customers with licensed health professionals, recently added mental health treatments and weight loss to their portfolio.
Techcrunch event
Berkeley, ca.
|
June 5
The company’s ambitions are reflected in its recent hiring. Earl this week, the company said that former Amazon Executive Nader Kabbani will be his next Head of Operations.
Dudum sees AI as technology that will help the company evolve and, ultimately, will serve more people. HIMS & HERS is between 10,000 and 15,000 patients per day, according to Dudum. The anonymized information of millions of patients, statistics such as clinical visits, the medications that are prescribed and if those medications work, have been collected in a massive data set. These data are now being used to create AI models that will eventually be used to help diagnose and treat patients.
Two years ago, the company trained a model as a data set to create MEDMCHA tool that helps doctors recommend treatments related to mental health. Dudum said that all their tools based on AI still have a human in the loop, specifically a doctor or other health professionals.
“There is a very strict and structured approach when it comes to clinical decision tools within the medical industry, so suppliers are, ultimately, from the regulatory point of view, still necessary to take all these judgments and clinical decisions,” Dudum said. He pointed out that the company’s products are there to give information and help suppliers more efficient and precise.
Dudum said that the company’s AI also shows doctors and health professionals how it reached its conclusions when making recommendations. “Show the work and really provide the type of context behind the scene in terms of what it drives and what weights are promoting the results, I think they are actually, in many ways, as valuable as the real recommendation,” he said.